Inotiv is a contract research organization providing drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. Co.'s segments include: contract research services, which provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing; and research products, which designs, develops, manufactures and markets: in vivo sampling systems and accessories; physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. The NOTV stock yearly return is shown above.
The yearly return on the NOTV stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NOTV annual return calculation with any dividends reinvested as applicable (on ex-dates).
|